Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

Archived 29: Summary of NACI statement of January 25, 2022: Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 29: Summary of NACI statement of January 25, 2022: Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca We have archived this page and will not be updating it.…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccines-children-5-11-years-age/summary.html

Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age - Canada.ca We have archived this page and will not be updating it. You can use it for…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccines-children-5-11-years-age/amendment-january-25-2022.html

Archived 29: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 29: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference.…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccines-children-5-11-years-age.html

Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 25: Summary of NACI rapid response of December 3, 2021: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 - Canada.ca Skip to main…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines/summary.html

Archived 25: NACI rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines [2021-12-03] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 25: NACI rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines [2021-12-03] - Canada.ca Skip…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mrna-vaccines.html

Archived 26: NACI updated guidance on booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 26: NACI updated guidance on booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference. Français fr…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-booster-covid-19-vaccine-doses.html

Archived 26: Summary of NACI updated guidance of December 3, 2021: Booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 26: Summary of NACI updated guidance of December 3, 2021: Booster COVID-19 vaccine doses in Canada [2021-12-03] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference.…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-booster-covid-19-vaccine-doses/summary.html

Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine/summary-february-17-2022.html

Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-medicago-covid-19-vaccine/summary-march-11-2022.html

Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age - Canada.ca We have archived this page and will not be updating it. You…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-use-booster-covid-19-vaccine-doses-adolescents-12-17-years-age/summary.html
Page 2412 sur 2498Affichage de 24111 à 24120 sur 24974
« Première← Préc.Suiv. →Dernière »

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.